{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:34:53Z","timestamp":1793036093233,"version":"4.5.0"},"reference-count":107,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD052740, R21RR030264, R21OD016564, R21HD086402, R01HD102386"],"award-info":[{"award-number":["R01HD052740, R21RR030264, R21OD016564, R21HD086402, R01HD102386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cancers of the female reproductive tract are both lethal and highly prevalent. For example, the five-year survival rate of women diagnosed with ovarian cancer is still less than 50%, and endometrial cancer is the fourth most common cancer in women with &gt; 65,000 new cases in the United States in 2020. Among the many genes already established as key participants in ovarian and endometrial oncogenesis, progesterone receptor membrane component (PGRMC)1 and PGRMC2 have gained recent attention given that there is now solid correlative information supporting a role for at least PGRMC1 in enhancing tumor growth and chemoresistance. The expression of PGRMC1 is significantly increased in both ovarian and endometrial cancers, similar to that reported in other cancer types. Xenograft studies using human ovarian and endometrial cancer cell lines in immunocompromised mice demonstrate that reduced expression of PGRMC1 results in tumors that grow substantially slower. While the molecular underpinnings of PGRMCs\u2019 mechanisms of action are not clearly established, it is known that PGRMCs regulate survival pathways that attenuate stress-induced cell death. The objective of this review is to provide an overview of what is known about the roles that PGRMC1 and PGRMC2 play in ovarian and endometrial cancers, particularly as related to the mechanisms through which they regulate mitosis, apoptosis, chemoresistance, and cell migration.<\/jats:p>","DOI":"10.3390\/cancers13235953","type":"journal-article","created":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T22:19:16Z","timestamp":1638137956000},"page":"5953","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer"],"prefix":"10.3390","volume":"13","author":[{"given":"John J.","family":"Peluso","sequence":"first","affiliation":[{"name":"Department of Cell Biology, University of Connecticut Health Center, Farmington, CT 06030, USA"},{"name":"Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, CT 06030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"Pru","sequence":"additional","affiliation":[{"name":"Department of Animal Science, Program in Reproductive Biology, University of Wyoming, Laramie, WY 82071, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","article-title":"The Origin of Ovarian Cancer Species and Precancerous Landscape","volume":"191","author":"Shih","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsbmb.2007.02.002","article-title":"Progesterone receptor membrane component 1: An integrative review","volume":"105","author":"Cahill","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.canlet.2014.09.036","article-title":"Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors","volume":"356","author":"Friel","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2007-2771","article-title":"Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1","volume":"93","author":"Peluso","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ebiom.2019.08.035","article-title":"Molecular mechanisms underlying mifepristone\u2019s agonistic action on ovarian cancer progression","volume":"47","author":"Chrusciel","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_6","first-page":"726","article-title":"Purification and Partial Sequencing of High-Affinity Progesterone-Binding Site(s) from Porcine Liver Membranes","volume":"239","author":"Meyer","year":"1996","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"ref_7","first-page":"640","article-title":"Conditional Ablation of Progesterone Receptor Membrane Component 2 Causes Female Premature Reproductive Senescence","volume":"158","author":"Clark","year":"2016","journal-title":"Endocrinology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1210\/en.2016-1081","article-title":"Conditional Ablation of Progesterone Receptor Membrane Component 1 Results in Subfertility in the Female and Development of Endometrial Cysts","volume":"157","author":"McCallum","year":"2016","journal-title":"Endocrinology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1021\/bi501177e","article-title":"Spectroscopic and Mutagenesis Studies of Human PGRMC1","volume":"54","author":"Kaluka","year":"2015","journal-title":"Biochemistry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5582\/bst.2017.01009","article-title":"The evolutionary appearance of signaling motifs in PGRMC1","volume":"11","author":"Cahill","year":"2017","journal-title":"Biosci. Trends"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"106814","DOI":"10.1016\/j.ympev.2020.106814","article-title":"Early eukaryotic origins and metazoan elaboration of MAPR family proteins","volume":"148","author":"Hehenberger","year":"2020","journal-title":"Mol. Phylogenet. Evol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1073\/pnas.091553298","article-title":"Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions","volume":"98","author":"Thornton","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1126\/science.1086185","article-title":"Resurrecting the Ancestral Steroid Receptor: Ancient Origin of Estrogen Signaling","volume":"301","author":"Thornton","year":"2003","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: A review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"72480","DOI":"10.18632\/oncotarget.19819","article-title":"Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells","volume":"8","author":"Willibald","year":"2017","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/GME.0000000000000739","article-title":"Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer","volume":"24","author":"Ruan","year":"2017","journal-title":"Menopause"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/09513590.2012.730572","article-title":"Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells","volume":"29","author":"Schneck","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian Cancer: An Integrated Review","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13048-019-0588-z","article-title":"Ovarian cancer stem cells and targeted therapy","volume":"12","author":"Keyvani","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: Epidemiology and risk factors","volume":"26","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","article-title":"Epidemiology of epithelial ovarian cancer","volume":"41","author":"Webb","year":"2017","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/0008-5472.CAN-19-2850","article-title":"The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)","volume":"80","author":"Trabert","year":"2020","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1158\/1055-9965.EPI-19-1628","article-title":"Dietary Intake of Acrylamide and Risk of Breast, En-do-metrial, and Ovarian Cancers: A Systematic Review and Dose-Response Meta-analysis","volume":"29","author":"Adani","year":"2020","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1515\/cclm-2017-0982","article-title":"Linking type 2 diabetes and gynecological cancer: An introductory overview","volume":"56","author":"Anastasi","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Levine","year":"2013","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.critrevonc.2010.11.005","article-title":"Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer","volume":"80","author":"Gadducci","year":"2011","journal-title":"Crit. Rev. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1095\/biolreprod.114.119255","article-title":"Influence of AKT on progesterone action in endometrial diseases","volume":"91","author":"Lee","year":"2014","journal-title":"Biol. Reprod."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/path.4056","article-title":"Use of mutation profiles to refine the classification of endometrial carcinomas","volume":"228","author":"McConechy","year":"2012","journal-title":"J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/met.2018.0106","article-title":"Metabolic Syndrome in Endometrial Cancer Patients: Systematic Review","volume":"17","author":"Adambekov","year":"2019","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/jwh.2018.6956","article-title":"Increased Incidence of Endometrial Cancer Following the Women\u2019s Health Initiative: An Assessment of Risk Factors","volume":"28","author":"Constantine","year":"2019","journal-title":"J. Womens Heal."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/1471-0528.12106","article-title":"Obesity-driven endometrial cancer: Is weight loss the answer?","volume":"120","author":"Mackintosh","year":"2013","journal-title":"BJOG"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/09513590.2020.1730794","article-title":"The polycystic ovary syndrome and gy-necological cancer risk","volume":"36","author":"Meczekalski","year":"2020","journal-title":"Gynecol. Endocrinol."},{"key":"ref_34","first-page":"652","article-title":"Long-term toxicities of selective estrogen-receptor modulators and antiaromatase agents","volume":"17","author":"Mortimer","year":"2003","journal-title":"Oncology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-992926","article-title":"Polycystic Ovary Syndrome and Endometrial Cancer","volume":"26","author":"Navaratnarajah","year":"2008","journal-title":"Semin. Reprod. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1210\/en.2011-2096","article-title":"Progesterone Regulation of Progesterone Receptor Membrane Component 1 (PGRMC1) Sumoylation and Transcriptional Activity in Spontaneously Immortalized Granulosa Cells","volume":"153","author":"Peluso","year":"2012","journal-title":"Endocrinology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1095\/biolreprod.115.131508","article-title":"Progestin and AdipoQ Receptor 7, Progesterone Membrane Receptor Component 1 (PGRMC1), and PGRMC2 and Their Role in Regulating Progesterone\u2019s Ability to Suppress Human Granulosa\/Luteal Cells from Entering into the Cell Cycle","volume":"93","author":"Sueldo","year":"2015","journal-title":"Biol. Reprod."},{"key":"ref_38","first-page":"339","article-title":"The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology","volume":"1866","author":"Cahill","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Bioenerg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"50822","DOI":"10.18632\/oncotarget.10691","article-title":"PGRMC1 regulation by phosphorylation: Potential new insights in controlling biological activity","volume":"7","author":"Cahill","year":"2016","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"D246","DOI":"10.1093\/nar\/gkx1158","article-title":"Expression Atlas: Gene and protein expression across multiple studies and organisms","volume":"46","author":"Papatheodorou","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4236\/alc.2015.43006","article-title":"PGRMC1 Elevation in Multiple Cancers and Essential Role in Stem Cell Survival","volume":"04","author":"Hampton","year":"2015","journal-title":"Adv. Lung Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1038\/s41598-021-84953-9","article-title":"Gene expression profile association with poor prognosis in epithelial ovarian cancer patients","volume":"11","author":"Oliveira","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/PAP.0000000000000243","article-title":"A Comprehensive Review of Ovarian Serous Carcinoma","volume":"26","author":"Hatano","year":"2019","journal-title":"Adv. Anat. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1210\/en.2009-0730","article-title":"Progesterone Receptor Membrane Component-1 Regulates the Development and Cisplatin Sensitivity of Human Ovarian Tumors in Athymic Nude Mice","volume":"150","author":"Peluso","year":"2009","journal-title":"Endocrinology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"R255","DOI":"10.1530\/ERC-12-0175","article-title":"Hormone response in ovarian cancer: Time to reconsider as a clinical target?","volume":"19","author":"Modugno","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1210\/en.2007-1050","article-title":"Progesterone Receptor Membrane Component-1 (PGRMC1) Is the Mediator of Progesterone\u2019s Antiapoptotic Action in Spontaneously Immortalized Granulosa Cells As Revealed by PGRMC1 Small Interfering Ribonucleic Acid Treatment and Functional Analysis of PGRMC1 Mutations","volume":"149","author":"Peluso","year":"2007","journal-title":"Endocrinology"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Thieffry, C., Van Wynendaele, M., Aynaci, A., Maja, M., Dupuis, C., Loriot, A., Marbaix, E., and Henriet, P. (2021). AG-205 Upregulates Enzymes Involved in Cholesterol Biosynthesis and Steroidogenesis in Human Endometrial Cells Independently of PGRMC1 and Re-lated MAPR Proteins. Biomolecules, 11.","DOI":"10.3390\/biom11101472"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1515\/hsz-2019-0417","article-title":"A progesterone receptor membrane component 1 antagonist induces large vesicles in-de-pendent of progesterone receptor membrane component 1 expression","volume":"401","author":"Eckhardt","year":"2020","journal-title":"Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1210\/endo.143.6.8885","article-title":"Global gene profiling in human endometrium during the window of implantation","volume":"143","author":"Kao","year":"2002","journal-title":"Endocrinology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/pr801024g","article-title":"Proteomic Characterization of Midproliferative and Midsecretory Human Endometrium","volume":"8","author":"Chen","year":"2009","journal-title":"J. Proteome Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1210\/en.2006-0114","article-title":"Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone\u2019s antiapoptotic action","volume":"147","author":"Peluso","year":"2006","journal-title":"Endocrinology"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Xiong, S., Mhawech-Fauceglia, P., Tsao-Wei, D., Roman, L., Gaur, R.K., Epstein, A.L., and Pinski, J. (2019). Expression of the luteinizing hormone receptor (LHR) in ovarian cancer. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6153-8"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/bs.vh.2018.01.019","article-title":"From Follicular Development and Ovulation to Ovarian Cancers: An Unexpected Journey","volume":"107","author":"Richards","year":"2018","journal-title":"Vitam. Horm"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"12816","DOI":"10.1073\/pnas.97.23.12816","article-title":"A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors","volume":"97","author":"Krebs","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.steroids.2007.12.017","article-title":"Progesterone receptor membrane component 1\u2014Many tasks for a versatile protein","volume":"73","author":"Besong","year":"2008","journal-title":"Steroids"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Stepanova, M., Lin, F., and Lin, V.C. (2006). In silico modelling of hormone response elements. BMC Bioinform., 7.","DOI":"10.1186\/1471-2105-7-S4-S27"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mce.2008.02.012","article-title":"Expression of progesterone receptor membrane component 1 and its partner serpine 1 mRNA binding protein in uterine and placental tissues of the mouse and human","volume":"287","author":"Zhang","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/molehr\/gas006","article-title":"Alterations in progesterone receptor membrane component 2 (PGRMC2) in the endometrium of macaques afflicted with advanced endometriosis","volume":"18","author":"Keator","year":"2012","journal-title":"Mol. Hum. Reprod."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0090-8258(90)90012-A","article-title":"Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance","volume":"38","author":"Kleine","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"E1316","DOI":"10.1210\/jc.2012-1018","article-title":"Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3","volume":"97","author":"Panda","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ali Syeda, Z., Langden, S.S.S., Munkhzul, C., Lee, M., and Song, S.J. (2020). Regulatory Mechanism of MicroRNA Expression in Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051723"},{"key":"ref_62","first-page":"273","article-title":"Involvement of let-7\/miR-98 microRNAs in the regulation of pro-gesterone receptor membrane component 1 expression in ovarian cancer cells","volume":"25","author":"Wendler","year":"2011","journal-title":"Oncol. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40169-019-0240-y","article-title":"Let-7as biomarker, prognostic indicator, and therapy for precision medicine in cancer","volume":"8","author":"Chirshev","year":"2019","journal-title":"Clin. Transl. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/07357907.2012.707265","article-title":"Reversal of Paclitaxel Resistance in Epithelial Ovarian Carcinoma Cells by a MUC1 Aptamer-let-7i Chimera","volume":"30","author":"Liu","year":"2012","journal-title":"Cancer Investig."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncrna.2016.10.003","article-title":"Role of let-7 family microRNA in breast cancer","volume":"1","author":"Thammaiah","year":"2016","journal-title":"Non-Coding RNA Res."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Cavallini, A., Lippolis, C., Vacca, M., Nardelli, C., Castegna, A., Arnesano, F., Carella, N., and DePalo, R. (2016). The Effects of Chronic Lifelong Activation of the AHR Pathway by Industrial Chemical Pollutants on Female Human Reproduction. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0152181"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1093\/carcin\/17.12.2609","article-title":"Isolation and characterization of a novel gene induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in rat liver","volume":"17","author":"Selmin","year":"1996","journal-title":"Carcinogenesis"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3203161","DOI":"10.1155\/2017\/3203161","article-title":"Mediating Roles of PPARs in the Effects of Environmental Chemicals on Sex Steroids","volume":"2017","author":"Huang","year":"2017","journal-title":"PPAR Res"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bjc.6602244","article-title":"Enhanced expression of peroxisome prolif-era-tor-activated receptor gamma in epithelial ovarian carcinoma","volume":"92","author":"Zhang","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.neo.7900119","article-title":"Heightened expression of cyclooxygenase-2 and perox-isome proliferator-activated receptor-delta in human endometrial adenocarcinoma","volume":"2","author":"Tong","year":"2000","journal-title":"Neoplasia"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s42003-020-01202-x","article-title":"Progesterone receptor membrane associated component 1 enhances obesity progression in mice by fa-cili-tating lipid accumulation in adipocytes","volume":"3","author":"Furuhata","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/17460441.2018.1426567","article-title":"The latest animal models of ovarian cancer for novel drug discovery","volume":"13","author":"Magnotti","year":"2018","journal-title":"Expert. Opin. Drug Discov."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbrc.2006.07.022","article-title":"RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells","volume":"348","author":"Materna","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"105376","DOI":"10.1016\/j.jsbmb.2019.105376","article-title":"Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1","volume":"191","author":"Sabbir","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Damia, G., and Broggini, M. (2019). Platinum Resistance in Ovarian Cancer: Role of DNA Repair. Cancers, 11.","DOI":"10.3390\/cancers11010119"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1095\/biolreprod.110.088385","article-title":"A novel role for progesterone and progesterone receptor membrane component 1 in regulating spindle microtubule stability during rat and human ovarian cell mitosis","volume":"84","author":"Lodde","year":"2011","journal-title":"Biol. Reprod."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1095\/biolreprod.114.122986","article-title":"Progesterone receptor membrane component-1 (PGRMC1) and PGRMC-2 interact to suppress entry into the cell cycle in spontaneously immortalized rat granulosa cells","volume":"91","author":"Peluso","year":"2014","journal-title":"Biol. Reprod."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1095\/biolreprod.114.117481","article-title":"Expression of Progesterone Receptor Membrane Component-2 Within the Immature Rat Ovary and Its Role in Regulating Mitosis and Apoptosis of Spontaneously Immortalized Granulosa Cells1","volume":"91","author":"Griffin","year":"2014","journal-title":"Biol. Reprod."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/biolre\/ioz043","article-title":"Progesterone receptor membrane component 1 and 2 regulate granulosa cell mitosis and survival through a NFKappaB-dependent mechanism","volume":"100","author":"Peluso","year":"2019","journal-title":"Biol. Reprod."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/en.2013-1991","article-title":"Enhancement of cell surface expression and receptor functions of membrane progestin receptor alpha (mPRalpha) by progesterone receptor membrane component 1 (PGRMC1): Evidence for a role of PGRMC1 as an adaptor protein for steroid receptors","volume":"155","author":"Thomas","year":"2014","journal-title":"Endocrinology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"14494","DOI":"10.1074\/jbc.M111.324921","article-title":"Neutrophil Gelatinase-associated Lipocalin (NGAL) Expression Is Dependent on the Tumor-associated Sigma-2 Receptor S2RPgrmc1","volume":"287","author":"Mir","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1038\/s41598-018-21322-z","article-title":"Progesterone Receptor Membrane Component 1 suppresses the p53 and Wnt\/beta-catenin pathways to promote human pluripotent stem cell self-renewal","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"24775","DOI":"10.1074\/jbc.M110.134585","article-title":"Pgrmc1 (Progesterone Receptor Membrane Component 1) Associates with Epidermal Growth Factor Receptor and Regulates Erlotinib Sensitivity","volume":"285","author":"Ahmed","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.18632\/oncotarget.14021","article-title":"Chemoresistance and targeted therapies in ovarian and endometrial cancers","volume":"8","author":"Brasseur","year":"2017","journal-title":"Oncotarget"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"55771","DOI":"10.18632\/oncotarget.9908","article-title":"Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer","volume":"7","author":"Deng","year":"2016","journal-title":"Oncotarget"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Klemba, A., Bodnar, L., Was, H., Brodaczewska, K.K., Wcislo, G., Szczylik, C.A., and Kieda, C. (2020). Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249492"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41416-019-0461-2","article-title":"Poor outcome in hypoxic endometrial carcinoma is related to vascular density","volume":"120","author":"Reijnen","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.3802\/jgo.2018.29.e32","article-title":"Chemoresistance in ovarian cancer: Exploiting cancer stem cell metabolism","volume":"29","author":"Li","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Giannone, G., Attademo, L., Scotto, G., Genta, S., Ghisoni, E., Tuninetti, V., Aglietta, M., Pignata, S., and Valabrega, G. (2019). Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications. Cancers, 11.","DOI":"10.3390\/cancers11111820"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41598-018-37441-6","article-title":"Epitope mapping of anti-PGRMC1 antibodies reveals the non-conventional mem-brane topology of PGRMC1 on the cell surface","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_92","first-page":"365","article-title":"PGRMC1\/2 promotes luteal vascularization and maintains the primordial follicles of mice","volume":"156","author":"Peluso","year":"2018","journal-title":"Reproduction"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/s41416-020-0825-7","article-title":"Chemotherapy exacerbates ovarian cancer cell migration and cancer stem cell-like characteristics through GLI1","volume":"122","author":"Zhao","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_94","first-page":"91","article-title":"Promotion of ovarian cancer cell invasion, migration and colony formation by the miR21\/Wnt\/CD44v6 pathway","volume":"42","author":"Wang","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.steroids.2012.09.006","article-title":"In vitro inhibition of SKOV-3 cell migration as a distinctive feature of proges-terone receptor membrane component type 2 versus type 1","volume":"77","author":"Albrecht","year":"2012","journal-title":"Steroids"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s12094-019-02249-x","article-title":"Oncologic impact of micrometastases or isolated tumor cells in sentinel lymph nodes of patients with en-dometrial cancer: A meta-analysis","volume":"22","author":"Ramirez","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ajog.2004.04.015","article-title":"Putative gene loci associated with carcinogenesis and metastasis of endocervical adenocarcinomas of uterus determined by conventional and array-based CGH","volume":"191","author":"Hirai","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"68894","DOI":"10.18632\/oncotarget.12028","article-title":"Diagnostic value of circulating miR-21: An update meta-analysis in various cancers and validation in endometrial cancer","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"11030","DOI":"10.1038\/ncomms11030","article-title":"Haem-dependent dimerization of PGRMC1\/Sigma-2 receptor facilitates cancer proliferation and chemo-resistance","volume":"7","author":"Kabe","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mce.2010.02.005","article-title":"Progesterone inhibits apoptosis in part by PGRMC1-regulated gene ex-pression","volume":"320","author":"Peluso","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.steroids.2012.01.013","article-title":"Evidence for a genomic mechanism of action for progesterone receptor membrane com-po-nent-1","volume":"77","author":"Peluso","year":"2012","journal-title":"Steroids"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biochi.2014.12.008","article-title":"mRNAs that specifically interact with eukaryotic ribosomal subunits","volume":"114","author":"Deforges","year":"2015","journal-title":"Biochimie"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1134\/S0006297912060028","article-title":"Ribosomal proteins: Structure, function, and evolution","volume":"77","author":"Korobeinikova","year":"2012","journal-title":"Biochemistry (Moscow)"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biochi.2014.12.011","article-title":"Heterogeneity of the translational machinery: Variations on a common theme","volume":"114","author":"Sauert","year":"2015","journal-title":"Biochimie"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"12031","DOI":"10.1073\/pnas.192442499","article-title":"The ribosome filter hypothesis","volume":"99","author":"Mauro","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1471-2164-10-365","article-title":"Correlations between RNA and protein expression profiles in 23 human cell lines","volume":"10","author":"Gry","year":"2009","journal-title":"BMC Genom."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","article-title":"Correlation of mRNA and protein in complex biological samples","volume":"583","author":"Maier","year":"2009","journal-title":"FEBS Lett."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/23\/5953\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:36:21Z","timestamp":1760168181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/23\/5953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":107,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["cancers13235953"],"URL":"https:\/\/doi.org\/10.3390\/cancers13235953","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]}}}